CAR-modified NK Cells Production Platform Launched by Creative Biolabs

Creative Biolabs, an advanced biotechnology service provider, is proud to announce the Chimeric Antigen Receptor-modified NK Cells production platform.

New York, US – July 24, 2018 – Creative Biolabs, an advanced biotechnology service provider, is proud to announce the Chimeric Antigen Receptor-modified NK Cells production platform.

 

Chimeric antigen receptor (CAR)-engineered T cell therapy is the most promising immunotherapy for cancer treatment, which has shown remarkable ability to eliminate various kinds of tumors, especially for B cell malignancies, with up to 95% response rates and durable complete remission.

 

In addition to genetically modified T cells, CAR engineered NK cells therapy has also become a rising adoptive immunotherapy. The expression of Chimeric Antigen Receptor through the CAR NK production platform can increase the specificity and the cytotoxicity effection of NK cells when they attack cancer cells.

 

NK cells, a lymphoid cell population of the innate immune system, play a central role in killing certain tumor cells via natural cytotoxicity, which can control the development of various cancers by limiting their metastasizing and subsequent tissue injury in the absence of previous immunization and MHC restriction.

 

Compared with T cells, CAR-NK cells are able to produce allogeneic NK cells without leading to the graft-versus-host disease. And suicide genes are not required for regulating CAR-NK cells life span in vivo, which decreases the side effects in clinical trials.

 

With leading-edge techniques and elite scientists, Creative Biolabs can offer customers CellRapeuticsTM Chimeric Antigen Receptor (CAR) construction service with the highest quality for engineering Natural Killer (NK) cells. Our worldwide popularity and credit have made Creative Biolabs a reliable cooperative friend in CAR NK construction field.

 

About Creative Biolabs

As a global company, Creative Biolabs have more than 200 talented and well-trained scientists located in different continents working closely with partners from the entire world to develop and produce medicines of tomorrow. Specifically, we are the established leading expert in TCR and CAR T&NK cell immune therapy development, as we offer the one-stop custom services that cover the entire new drug development pipeline. Additionally, we also offer an exclusive line of ready-to-use TCR and CAR T&NK cell construction products, such as virus packaging, purification, expansion and titer determination kits. Furthermore, we have built up a unique unparalleled CAR construction and production platform for all four CAR generations.

Media Contact
Company Name: Creative Biolabs
Contact Person: Bella Smith
Email: Send Email
Phone: 1-631-619-7922
Address:45-1 Ramsey Road
City: Shirley
State: New York
Country: United States
Website: https://www.creative-biolabs.com/car-t